Mission BioCapital
Mission BioCapital is an early-stage venture capital firm that invests in life sciences companies, with a stated emphasis on novel therapeutics and opportunistic investments in medtech and diagnostics. The firm combines capital with access to shared lab space, incubation partners, discovery service providers, and strategic mentorship. It operates offices in Cambridge, MA and San Francisco, CA and runs the Mission BioCapital Platinum Program to provide pre-seed funding, incubator bench space and services to launch early-stage biotech companies.
Industries
Nr. of Employees
small (1-50)
Mission BioCapital
953 Indiana Street, San Francisco, CA 94107
Portfolio
San Francisco-based; focused on discovering and developing small-molecule therapeutics for Alzheimer’s disease.
#Life sciences / biotechnology
Cambridge, MA-based; developing robotics and evolution approaches for drug discovery targeting cardiometabolic inflammatory diseases and oncology.
#Life sciences / biotechnology
Yale spinout (New Haven) developing engineered tRNA therapeutics for oncology.
#Life sciences / biotechnology
Cambridge, MA-based; developing a novel oligonucleotide platform with initial focus on CNS diseases.
#Life sciences / biotechnology
Heidelberg, Germany spinout (EMBL) targeting tRNA-based approaches for cancer and immune diseases.
#Life sciences / biotechnology
San Carlos, CA (Stanford spinout) developing high-throughput platforms for selectivity-first allosteric small-molecule discovery.
#Life sciences / biotechnology
San Francisco-based; focused on discovering and developing small-molecule therapeutics for Alzheimer’s disease.
#Life sciences / biotechnology
Cambridge, MA-based; developing robotics and evolution approaches for drug discovery targeting cardiometabolic inflammatory diseases and oncology.
#Life sciences / biotechnology
Yale spinout (New Haven) developing engineered tRNA therapeutics for oncology.
#Life sciences / biotechnology
Cambridge, MA-based; developing a novel oligonucleotide platform with initial focus on CNS diseases.
#Life sciences / biotechnology
Heidelberg, Germany spinout (EMBL) targeting tRNA-based approaches for cancer and immune diseases.
#Life sciences / biotechnology
San Carlos, CA (Stanford spinout) developing high-throughput platforms for selectivity-first allosteric small-molecule discovery.
#Life sciences / biotechnology